Plain-English translation of NCT07235111 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Alzheimer Disease research guide →Researchers are studying what causes neurodegenerative diseases—conditions like Alzheimer's disease, Parkinson's disease, ALS, and dementia—by analyzing genetic material and proteins in blood and saliva samples from affected patients. By looking at your genes, gene activity, and proteins in detail, they hope to find new ways to diagnose these diseases earlier, predict how they might progress, and eventually understand how to treat them better.
Right now, doctors diagnose brain diseases mainly based on symptoms, which often appear late in the disease. This study exists to find biological markers—measurable signs in blood or other samples—that could help doctors catch these diseases earlier and understand why they develop in the first place.
You likely qualify if…
You likely don't qualify if…
You would visit one of the research centers (in Genoa or Milan, or another approved location) during a regular doctor's appointment. During that visit, researchers would collect samples of your blood, saliva, and urine—similar to routine medical tests. Your samples would then be analyzed using advanced genetic and protein-testing technologies to look for patterns that might help doctors understand your condition better. The study involves 1,200 people total and is ongoing, so participation timing depends on when you enroll.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
Italy